✦ LIBER ✦

Phase II study of ifosfamide as a single drug for relapsed paediatric patients

✍ Scribed by E. Schwartzman; M. Scopinaro; N. Angueyra

Publisher: Springer
Year: 1989
Tongue: English
Weight: 170 KB
Volume: 24
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00253230

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of ifosfamide in paedia

A phase II study of ifosfamide in paediatric solid tumours

✍ C. R. Pinkerton; J. Pritchard 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 297 KB

Phase II study of carboplatin as a singl

Phase II study of carboplatin as a single drug for relapsed Wilms' tumor: Experience of the Brazilian Wilms' tumor study group

✍ De Camargo, Beatriz ;Melaragno, Renato ;Silva, Nagsla Saba E ;Mendoncla, Nubia ; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB

## Abstract A total of 15 patients with relapsed Wilms' tumor were treated with carboplatin as a single agent. There were six females and nine males, aged between 2 and 9 years (me‐dian:5). The treatment consisted of carboplatin given I.V. as a single agent at a dose of 550 mg/m^2^ over 1 hour ever

A phase II study of ifosfamide in advanc

A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix

✍ R. E. Coleman; P. G. Harper; C. Gallagher; R. Osborne; E. M. Rankin; A. C. Silve 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 405 KB

A phase II study of ifosfamide and cispl

A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix

✍ R. E. Coleman; J. M. Clarke; M. L. Slevin; J. Sweetenham; C. J. Williams; P. Bla 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 363 KB

A phase II study of ifosfamide in the tr

A phase II study of ifosfamide in the treatment of relapses in Wilms' tumor

✍ Marie France Tournade 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 202 KB

The purpose of this study was to evaluate the antitumor activity and tolerability of ifosfamide (IFO) at a dose of 3 g/m2, given on 2 consecutive days every 2 weeks, in advanced Wilms' tumor patients in whom conventional therapy had failed. Mesna and hyperhydration were concomitantly given to minimi

A Phase II study of paclitaxel and ifosf

A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urothelium

✍ Christopher J. Sweeney; Stephen D. Williams; David E. Finch; Richard Bihrle; Ric 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 2 views

## BACKGROUND. Cisplatin-based combination chemotherapy for patients with advanced transitional cell carcinoma (TCC) of the urothelium has limitations, and new therapies need to be evaluated. METHODS. Ifosfamide 1.0 gm/m 2 on Days 1-4 and paclitaxel 135 mg/m 2 by 24-hour infusion on Day 4 were ad